Influenza A virus (IAV) infects a remarkably wide variety of avian and mammalian hosts. Evolution finely hones IAV genes to optimally infect and be transmitted in a particular host species. Sporadically, IAV manages to jump between species, introducing novel antigenic strains into the new host population that wreak havoc until herd immunity develops. IAV adaptation to new hosts typically involves reassortment of IAV gene segments from coinfecting virus strains adapted to different hosts in conjunction with multiple adaptive mutations in the various IAV genes. To better understand host adaptation between mammalian species in real time, we passaged mouse-adapted A/PR8/34 (PR8) in guinea pigs. Guinea pigs, unlike mice, support spontaneous and robust IAV transmission. For some IAV strains, including PR8, adaptation is required for a virus to attain transmissibility, providing an opportunity to understand the evolution of transmissibility in guinea pigs. Multiple guinea pig-adapted PR8 mutants generated by serial nasal wash passaging in independent lines replicated more efficiently and were transmitted by cocaging. All transmissible variants possessed one of two nonsynonymous mutations in M1, either alone or in combination with mutations in PB2, HA, NP, or NA. Rapid reassortment between independently selected variants combined beneficial mutations in NP and M1 to form the fittest virus capable of being transmitted. These findings provide further insight into genetic determinants in NP and M1 involved in PR8 IAV adaptation to be transmitted in a new host and clearly show the benefit of a segmented genome in rapidly generating optimal combinations of mutations in IAV evolution.
I
nfluenza A virus (IAV) remains an important human pathogen due to its antigenic variability. IAV provides a constantly moving target for the humoral immune system due to gradual antigenic evolution (antigenic drift) and abrupt shifts in antigenicity (antigenic shift). Antigenic shift results from the remarkable ability of IAV to adapt to a wide variety of avian and mammalian hosts, which creates genetically distinct reservoirs from which antigenically novel variants can invade the human population and cause devastating pandemics.
While avian species harbor the largest and most diverse IAV populations (1) (2) (3) , viruses replicating in mammals historically pose the most immediate threat to humans (4) . This was recently demonstrated by the 2009 swine origin H1N1 IAV pandemic (pH1N1) (5) . Two key features of IAV enhance its adaptability. First, its segmented genome enables rapid reassortment of the 8 gene segments encoding the 13 defined gene products (6, 7) . Reassortment plays a central role in IAV evolution, particularly in host adaptation, in which invading virus strains can rapidly acquire host-optimized alleles from the endemic virus. For example, swine, which are permissive to many avian and human viruses, can generate reassortant viruses with antigenically novel avian glycoproteins combined with internal genes adapted for replication in mammals (3, 4) . Second, a mutation rate just below the catastrophe limit (8) allows IAV to rapidly sample the available mutation space to optimize viral replication in new hosts as well as generate immune escape variants.
Different in vivo models of influenza virus infection provide unique views of IAV evolution (9) . Viral determinants of host adaptation and pathogenicity have been studied extensively in mice and ferrets using forward and reverse genetics approaches (reviewed in references 10, 11, and 12) . Guinea pigs (GPs) support replication and transmission of a wide variety of influenza viruses and have been increasingly utilized as a relatively low-cost alternative to the ferret transmission model (13) (14) (15) . Here, we explore the evolution of mouse-adapted IAV as it adapts to propagate and be transmitted in the GP.
MATERIALS AND METHODS

Viruses.
A/Puerto Rico/8/1934 (PR8) was generated using an 8-plasmid molecular clone rescue system (16) (GenBank accession numbers AF389115 to AF389122), generously contributed by Adolfo Garcia-Sastre. This clone differs from the published sequence (above) at two positions: PB1 A549C (K175N) and HA A651C (I207L) (H1 numbering). We generated seed virus by transfecting 293T cells with the 8-plasmid molecular clone. Output virus was then expanded once in Madin-Darby canine kidney (MDCK) cells and then in embryonated chicken eggs. Molecularclone-derived mutants were generated using site-directed mutagenesis as described previously (17) . All molecular-clone-derived viruses were expanded on MDCK cells in Gibco minimal essential medium (MEM) with GlutaMAX (Life Technologies, Grand Island, NY) supplemented with 1 g/ml of tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin. All tissue culture and nasal wash-derived virus titers were determined by endpoint dilution on MDCK cells, and the 50% tissue culture infective doses (TCID 50 s) were determined using the Reed-Muench method. Virus plaques were prepared on MDCK monolayers under an agarose overlay as previously described (18) .
Infections and passaging. We conducted research in compliance with the PHS policy, Office of Laboratory Animal Welfare (OLAW), guidance and all guidelines of the NIAID Institutional Animal Care and Use Committee (IACUC). Research was conducted under a protocol approved by the NIAID IACUC. Specific-pathogen-free female Hartley strain GPs were obtained from Charles River Laboratories (Frederick, MD). Animals used in all experiments were age matched and from the same cohort, which ranged from 5 to 12 weeks old. For infections, guinea pigs were anesthetized by isoflurane inhalation and infected intranasally (i.n.) with the TCID 50 s indicated below in 300 l of balanced salt solution containing 0.1% bovine serum albumin (BSA). Nasal washes were collected from isoflurane-anesthetized GPs by inserting 1 ml of phosphate-buffered saline, supplemented with 100 U/ml of penicillin and 100 g/ml of streptomycin, into one nostril while flowthrough was collected from the opposite nostril.
We initiated GP passage lines by intranasal infection with an egg stock of the molecular-clone-derived PR8 and maintained virus in GPs in parallel using age-matched animals from the same purchased cohort. In passages 1 to 10, animals 8 to 12 weeks old (mode ϭ 8 weeks old) were used. In passages 11 to 20, animals 5 to 10 weeks old (mode ϭ 6 weeks old) were used. Nasal wash samples taken at 48 h postinfection were either aliquoted, flash frozen on dry ice, and stored at Ϫ80°C or used immediately to inoculate the succeeding guinea pig and then flash frozen for further analysis. Aliquots from frozen samples were used to continue passage lines when necessary. In the first 5 passages, 300 l of undiluted nasal wash was used for inoculations. Thereafter, 30 l of nasal wash was diluted 1:10 in 270 l of balanced salt solution (BSS) containing 0.1% BSA and used for infections.
Transmission experiments. We performed transmission experiments under the controlled ambient humidity and temperature conditions in the vivarium. Relative humidity and temperature for all experiments ranged from 42 to 62% and 21 to 22.8°C (median values, 54% and 22°C). Animals from the same cohort were used in individual experiments. Ages of cohorts ranged from 5 to 8 weeks (mode ϭ 6.5 weeks). Recipient animals were cocaged with donor animals at 24 h postinfection and were monitored for infection by nasal wash at the frequencies indicated below. All statistical analyses were performed using Prism 5 (Graphpad, La Jolla, CA).
Calculation of relative fitness. For the competition experiment analysis illustrated in Table 1 , variant frequencies were estimated by sequencing plaque-cloned viruses. We calculated relative fitness (w) of the PR8 gpAB20 -derived genotypic variants using the following equation:
where p and q are frequencies of the PR8 gpAB20 -and PR8 gpA10 -derived variants in the input sample (0) and at 48 h postinfection (t). Here, t ϭ 6 generations (assuming 8 h/generation).
RT-PCR and sequencing. RNA was extracted from tissue culture and biological samples using a QiaAmp viral RNA minikit (Valencia, CA) and was reverse transcribed using a minus-strand-specific universal primer mix (5=-AGCRAAAGCAGG-3=) and an Abgene Verso reverse transcription-PCR (RT-PCR) kit (Thermo Scientific, Rockford, IL). PCR was performed using Platinum Taq HiFi DNA polymerase (Invitrogen Life Technologies, Grand Island, NY) with segment-specific or universal influenza virus primers described elsewhere (19) . PCR samples were sequenced using specific primers (sequences available upon request) for each segment and processed for Sanger sequencing using BigDye Terminator technology (Invitrogen Life Technologies) and run on an ABI 3730xl sequencer.
RESULTS
Adaptation of PR8 to GPs by serial passaging. A/Puerto Rico/8/ 1934 (PR8) has been extensively passaged in mice, eggs, and cultured cells over its long history (20, 21) . In contrast to A/California/04/2009 (CAL), which, like other human isolates, replicates to high titers and is transmitted well between GPs (22-24), PR8 fails to be transmitted between cocaged animals ( Fig. 1A and B) . Compared to CAL, PR8 exhibits over a 100-fold reduction in average nasal wash titer at 48 h postinfection (p.i.) and reaches a 10-foldlower mean peak titer, which is delayed by 48 h (Fig. 1E and F) . PR8 therefore provides an opportunity to characterize IAV adaptive evolution in a new host.
We passaged a molecular-clone-derived PR8 virus (PR8 WT ) through 10 serial GP nasal wash infections in two separate lines (PR8 gpAn and PR8 gpBn , where n ϭ number of passages), which were then combined (PR8 gpABn ) and passaged for an additional 10 rounds. We initiated passages PR8 A and PR8 B with 10 5 and 10 6 TCID 50 s, respectively. In the 5 initial rounds, the minimum input passaging doses for PR8 gpA and PR8 gpB were 3. TCID 50 s. In subsequent passages, to maximize viral replication, we decreased the input 10-fold for each passage line, using between 1.6 ϫ 10 3 and 5 ϫ 10 3 TCID 50 s for infection. At these doses, mutants representing Ͼ0.2% or Ͼ0.06%, respectively, of the donor population could reasonably be expected (95% confidence) to be sampled for the next round of infection (25) , thus limiting the severity of the interpassage bottleneck.
Increased replication kinetics and transmissibility of GPadapted PR8. After their initial 10 independent passages, we assessed the replication kinetics of PR8 gpA10 and PR8 gpB10 and their ability to be transmitted between cocaged GPs. A naïve recipient GP was cocaged 1 to 1 with each of 3 donors intranasally infected with PR8 gpA10 or PR8 gpB10 viruses. Both PR8 gpA10 (3 of 3) and PR8 gpB10 (2 of 3) were transmitted to naïve cage mates ( Fig. 1C and D), indicating that PR8 was adapting rapidly to its new host. Animals infected with PR8 gpA10 and PR8 gpB10 viruses showed a 2-to 3-log 10 increase in nasal wash titers at 48 h compared to animals infected with PR8 WT (Fig. 1E ) and also reached peak virus titer earlier than PR8 WT -infected GPs (Fig. 1F ). We could detect no significant differences in replication kinetics or transmission rates between PR8 gpA10 and PR8 gpB10 viruses ( Fig. 1C to F) , indicating that the two lines were similarly adapted to GPs.
M1 mutations are rapidly selected during GP adaptation. Bulk genomic sequencing of selected PR8 gpA and PR8 gpB passages demonstrated that increased replication kinetics and transmissibility were accompanied by nonsynonymous substitutions in multiple genes (Fig. 2) . Interestingly, the earliest detectable substitutions were clearly present by passage 3, M1 F62L in PR8 gpA and M1 V166M in PR8 gpB , each reaching 100% by passage 5 and stable thereafter ( Fig. 2A to F) . Their rapid independent emergence in each line suggests relatively strong selection for substitutions in M1. Accumulation of nonsynonymous substitutions in NP. Unlike PR8 gpB , PR8 gpA accumulated additional nonsynonymous substitutions in multiple genes between passages 3 and 10 ( Fig. 2 ). Variability increased with passaging, with segment 5, encoding NP, exhibiting the greatest diversity. NP T378A and NP F346S emerged as minor variants by passages 3 and 5, respectively. By passage 10, these substitutions were joined by NP A336T and NP M159I in the population.
In the PR8 gpA10 population, we established intragenic linkage for NP substitutions A336T and M159I and found that the NP M159I/A336T , NP F346S , and NP T378A substitutions were mutually exclusive ( Fig. 2E and G) . This, along with the clustering of these substitutions, both structurally and within a 44-amino-acid region, suggests functional similarity (see Discussion). Nonsynonymous mutations emerged in other genes, including NA K272R , HA H130Y , and linked substitutions PB2 Q194K and PB2 T683I . Unlike variants of PB2, NA, and HA, which remained as minority species, NP variants arose early in passaging and jointly outcompeted the wild-type variant on the background of the M1 F62L in line A ( Fig.  2A, C , and E) but not on the background of M1 V166M in line B. These findings imply relatively strong selection for these substitutions, and thus a role for NP in adaptation of PR8 to GPs, in the context of a subset of M1 substitutions.
Sequencing of 60 plaque clones revealed that the allelic variants of the PB2, HA, NP, and NA genes constituted at least 15 genotypes (combinations of alleles) (Fig. 2G) , clearly demonstrating the high frequency of segment reassortment during GP passaging. The 6 most abundant genotypes comprised 72% of the population, and each ranged from 7 to 17% in frequency, indicating no strong selective advantage for any single assortant during serial nasal wash passaging.
Transmission of multiple minor variants from diverse donor populations. Which genotypes in the diverse PR8 gpA population are best transmitted to naïve cage mates? Only the single genotype representing the prevalent virus in line B was transmitted to cage mates ( Fig. 1D and 2F ). In contrast, transmitted viruses replicating in GPs cocaged with PR8 gpA10 -infected animals (Fig. 1C) consisted of distinct genotypes, both within and between recipient animals (Fig. 3) . Importantly, all transmitted genotypes contained the M1 F62L allele, the dominant allele in the donor input population (Fig. 2G) . The genotypes that dominated in transmission recipients 101 and 102 ( Fig. 3A and B) represented 3% or less of the PR8 gpA10 input population genotypes (Fig. 2G) . Remarkably, both of these transmitted viruses possessed HA H130Y and NA K272R together despite their mutual exclusivity (P Ͻ 0.001) in the PR8 gpA10 population at peak titer (Fig. 2G ). All variants sampled from re- WT , CAL, and GP-adapted PR8 (gpA10 and gpB10). Titer data from appropriately dosed GPs depicted in panels A to D were included in the analysis in panels E and F in addition to data from animals infected but not cocaged for transmission tests. Means Ϯ standard errors of the means are plotted. ***, P Ͻ 0.001; **, P Ͻ 0.01 (one-way analysis of variance). cipient 102 possessed an additional NA substitution, K250R, and a subset of clones (6/25) possessed a V591I substitution in PB1, which were not detected in the donor population (0/28 clones). Recipient 103 had a mixed population dominated by two genotypes: one with PB2 Q194K/T683I , HA H130Y , and NP T378A and one with NP F346S and NP A284T , an additional substitution not detected in the PR8 gpA10 input population.
Together, these data indicate the following: (i) the multiple variants that appear during serial GP nasal wash passaging are capable of transmission, (ii) minor and even undetected genotypic variants can be transmitted from the donor population, and (iii) multiple variants can be transmitted to a single recipient during cohabitation, indicating a relatively wide bottleneck.
Reassortment between IAV lines A and B generates a fitter transmissible virus. Given the distinct evolutionary pathways exhibited by PR8 gpA and PR8 gpB viruses, which is fitter in GPs? Passaging a 1:1 mixture of the two populations for 10 rounds (generating the PR8 gpAB20 virus) resulted in genotypes carrying the M1 V166M allele (29/32 clones) outcompeting those carrying M1 F62L (3/32 clones) ( Fig. 4A and B) and the emergence of a major set of genotypes (17/32 clones) encoding both M1 V166M and NP F346S , presumably a result of reassortment between preexisting variants in PR8 gpA10 and PR8 gpB10 (Fig. 4B) . We did not detect the PR8 gpA10 allelic variants NP M159I/A336T , NP T378A , HA H130Y , and NA K272R , but we found a novel substitution, PB2 T521I , in a substantial fraction of clones (14/32) in combination with NP F346S , M1 V166M , and M1 F62L variants in the PR8 gpAB20 population.
Importantly, PR8 gpAB20 -derived viruses maintained their ability to transmit to naïve cage mates (Fig. 4C ) and demonstrated increased fitness relative to PR8 gpA10 viruses in coinfected animals (Fig. 5) . Virus sampled from the 4 transmission recipients cocaged with donors infected with PR8 gpAB20 (Fig. 4D to G) represented 2 of the 6 genotypic variants detected in the PR8 gpAB20 donor input population (Fig. 4B) . Transmitted variants contained NP F346S and M1 V166M , either with (1) or without (3) PB2 T521I (Fig. 4D to G) . When we mixed PR8 gpAB20 NP F346S M1 V166M approximately 1:1 in donor animals with either of two clonal variants (PR8 gpA10.101 or PR8 gpA10.102 ) transmitted from the PR8 gpA10 population (Fig. 3A and B), PR8 gpAB20 NP F346S M1 V166M rapidly outcompeted the PR8 gpA10 -derived viruses in infectivity and replication (Fig. 5) . While we detected reassortment between competing viruses, we found that viruses possessing the PR8 gpAB20 -derived NP F346S and M1 V166M allelic variants exhibited a distinct fitness advantage over those with the PR8 gpA10 -derived NP and M1 variants (Table 1 ). In the 3 transmission events for which a genotype could be determined (adequate genotype data could not be obtained for the transmission recipient paired with GP 1B, which had the lowest virus titer), virus with the complete PR8 gpAB20 NP F346S M1 V166M genotype was transmitted in 2 cases, but in 1 case, the transmitted virus was a reassortant containing the PR8 gpA10 -derived PB1 V591I , HA H130Y , NA K250R/K272R , and NP M159I/A336T allelic variants along with the PR8 gpAB20 -derived M1 V166M variant (Fig. 5) .
Together, these data are consistent with increased fitness, conferred specifically by the allelic variants NP F346S and M1 V166M , as the basis for the dominance of PR8 gpAB20 variants over PR8 gpA10 variants in the passage 20 virus population, as opposed to stochastic effects.
Mutations in either NP or M1 increase viral replication and transmissibility and are selected for their combined effect. Both the M1 F62L (in PR8 gpA ) and the M1 V166M (in PR8 gpB ) substitutions alone conferred transmissibility when reintroduced singly into the wild-type background by reverse genetics (Fig. 6 A and B) . However, M1 V166M , together with NP F346S , outcompeted M1 F62L when passages were combined (Fig. 4) . In order to determine the relative contributions of NP F346S and M1 V166M to IAV GP replication and transmission, we generated molecular-clone-derived single mutants. NP F346S and M1 V166M substitutions each conferred transmissibility, as did the NP F346S /M1 V166M double mutant (Fig.  6B to D) . Single mutants also conferred more rapid and robust growth kinetics relative to PR8 WT virus (P Ͻ 0.01) but were not clearly distinguishable from the double mutant by this measure (Fig. 6E) . Thus, a growth and transmissibility advantage in guinea pigs can be conferred by a single mutation encoding an amino acid substitution in either NP or M1.
In order to maximize sensitivity to detect differences in relative transmissibility between the single and double mutants, we infected GPs with a mixture of the single NP F346S and M1 V166M mutants at a 1:1 ratio. Each of 6 animals, infected intranasally (i.n.) with the mutant mixture, was then cocaged 1:1 with naïve GPs. Three of the 6 infected animals transmitted to naïïve cage mates (Fig. 7A) . In each case, the transmitted virus was the reassortant NP F346S /M1 V166M double mutant (the lack of transmission between 3 pairs may reflect the 50% transmission efficiency of these variants when directly competing with each other). Analysis of cloned viruses isolated from three of the donor animals (two transmitters and one nontransmitter) (Fig. 7B) revealed that the double mutant was generated in the donor and was represented at 18 to 43% at peak titer in these animals, indicating a selective advantage in growth and transmission for this combination of alleles over the single mutants alone. Interestingly, the reciprocal reassortant, wild-type (WT) PR8, was also detected at 6 to 14%, consistent with the idea that a large number of independent reassortment events may have contributed to the observed frequencies of both the WT and double mutant viruses, rather than relative growth advantage alone. This also demonstrates that substantially less fit viruses generated by reassortment can arise and persist in an infection, if not be transmitted. Together, these results demonstrate a positive interaction between NP F346 and M1 V166M in increasing fitness and highlight the advantage of a segmented genome in accelerating viral adaptation to a new host.
DISCUSSION
Understanding IAV host adaptation requires studying multiple virus strains in multiple animal infection models. Thanks to the Palese laboratory, the GP has been rediscovered and developed as a robust model of IAV transmission (11, 13, 14) . In this study, we have explored IAV evolutionary dynamics during serial passaging and transmission of mouse-adapted PR8 in GPs. Our major finding is that while the virus samples multiple genetic pathways during adaptation, mutations in the NP and M1 genes are central to increasing GP replication and transmission of PR8 and further implicate these genes in host adaptation in general.
PR8, which has a long and varied passage history in laboratory mice, embryonated chicken eggs, and immortalized canine cells, does not replicate well and is not transmitted in GPs, unlike other IAVs isolated from humans or other mammals (23, 24, 28) . PR8 therefore provides a unique angle to probe the genetics of host adaptation, particularly mammal-to-mammal adaptation, since most studies examine adaptation of avian viruses to mammals (29) .
The M1 gene is a known determinant of IAV respiratory droplet transmission in GPs, based on studies with reassortant virus expressing the M1 gene of the 2009 swine origin H1N1 (SOIV) virus on the background of PR8 genes (22) . Recent outbreaks in humans of variant swine H3N2 viruses containing the M1 gene of the 2009 SOIV confirm the critical role of this gene in host adaptation and transmission (26) . We extend these findings by demonstrating that GP replication and transmission are enhanced by F62L or V166M substitutions in M1. While some distance separates these substitutions in the linear sequence, their physical relationship remains unclear due to a lack of structural information. Neither of these residues is among the 13 residues that differ between the 2009 SOIV and PR8 M1 proteins, although the V167A in SOIV M1 may function similarly based on proximity and similarity to V166M.
We found that mutations in NP alone play a significant role in GP adaptation of PR8, extending findings from mouse adaptation studies of human SOIV and avian viruses pointing to a contribution from NP in determining host specificity (30, 31) . All the NP substitutions we identified (except M159I, which is linked to A336T) cluster in a region thought to influence NP-PB2 interactions (27, 32) , suggesting a common function. While all NP sub- stitutions are at highly conserved positions in natural isolates, A336T and F346S in particular are adjacent to variable positions. Gabriel and colleagues found that N319K, which is physically proximal to GP adaptation-associated residues A336T, F346L, and T378A, is associated with mouse adaptation and modulates polymerase activity through interaction with host importin-alpha isoforms (30, 33) . NP has also been implicated in Mx protein sensitivity (34) . Addressing the mechanisms underlying M1 and NP adaptation to GPs is clearly an important area of future research.
The difference in evolutionary rates in line A and B passage populations is intriguing. Line A, which acquired and fixed the M1 F62L substitution early, continued to accumulate substitutions in other genes, most notably in the NP gene. In contrast, line B acquired and fixed M1 V166M early but did not accumulate additional substitutions. One explanation for this observation is that line B experienced more severe bottlenecks during passaging. While lines A and B were initiated with 10 5 and 10 6 TCID 50 s, respectively, in the first 5 passages, line A infectious dosing did not drop below 5 ϫ 10 4 , whereas at passage 2 the line B dose dropped to 5 ϫ 10 3 . Even at this lower dose, however, we expect to sample any variant at Ͼ0.1% in the population. Alternatively, the virus carrying the M1 V166M allelic variant, which outcompeted the M1 F62L allelic variant in both passaging (Fig. 4A ) and the repeated-competition experiment (Fig. 5) , may be at a fitness peak where additional mutations are more likely to be detrimental or nearly neutral, slowing further evolution. To make this conclusion requires additional experiments that gauge the effects of further mutations on the fitness of each virus lineage.
High and variable rates of reassortment between competing viruses, and a dynamic environment (e.g., finite numbers of susceptible cells, selective pressures at the point of initial infection may be distinct from those later on, etc.), complicate the interpretation of our estimations of relative fitness measurements in Table  1 . While we expect beneficial alleles to dominate over the course of passaging, obtaining fitness estimations for a given allele, or genotype, that accurately predict the time to fixation over multiple passages may not be pragmatically possible in this context. Instead, our fitness estimations in Table 1 are intended to demonstrate, roughly, the relative fitness advantage that one allele or set of alleles has over another in the course of a 48-h infection. For example, in spite of the M1 V166M mutant exhibiting a distinct growth advantage over M1 F62L (Fig. 4A and 5) , the former does not become fixed at 100% over 10 guinea pig passages. We believe that while this means that M1 V166M is the fittest allele in the course of a single infection, we are not accounting for all the selective pressures present during passaging or the effect that reassortment with a competing virus has on allele frequency in a dynamic environment. This is most strikingly demonstrated in the data illustrated in Fig. 7B , which shows the spontaneously generated WT PR8 genotype is present at 6 to 14% in the population in spite of exhibiting a substantial growth defect in guinea pigs (Fig. 6E) and disappearing within 5 guinea pig passages (Fig. 2C and D) .
Efficient recombination through genome segment reassortment greatly enhances IAV evolution by combining preexisting beneficial mutations that have additive or synergistic effects on fitness. While no additional substitutions appeared in line B after the fixation of M1 V166M , when line A and B viruses were copassaged, the line A substitution NP F346S combined with M1 V166M from line B, increasing fitness of the resulting reassortant ( Fig. 4B and Table 1 ), which outcompeted each single-mutant parent during transmission (Fig. 7) . This combination of alleles may have been unlikely to have reached fixation in the absence of reassortment if a spontaneously generated double mutant lacked a large enough fitness advantage to overcome the frequency threshold to be carried forward, greater than 0.1% in nasal wash passaging and likely much higher for natural transmission. However, as illustrated in Fig. 7B , multiple in vivo reassortment events between two single mutants resulted in double mutants appearing at Ͼ20% at peak titer and allowed for transmission of the double mutant reassortant. Thus, this model emphasizes the role of reassortment, in complementing spontaneous mutation, as a key feature of IAV adaptability.
The transmission of multiple variants, observed in this study and in other transmission models (35) (36) (37) (38) , suggests that the transmission bottleneck in IAV may not be so severe in many circumstances, which would enhance the diversity on which selection can act in transmission recipients. The mode of transmission likely impacts the size of the bottleneck. In a "contact transmission" model described here, all modes of transmission, from direct contact with nasal secretions to aerosolized virus, can contribute to transmission (imagine child day care), with each mode potentially delivering different doses of virus or viruses with different biological properties. In addition, multiple variants can be transmitted to the recipient animals either in a "single" transmission event or sequentially over several hours of cohabitation. In either case, the transmission of diversity may allow variants with moderate fitness advantages to emerge and grow out over the course of multiple transmission events. Preexisting immunity in guinea pigs has been shown to impact virus evolution during the course of a single infection (39) , which raises the possibility of modeling in GPs viral evolution during transmission to animals with various states of preexisting immunity, as has been demonstrated in swine, horses, and dogs (36, 37, 40) .
The clear advantages of reassortment as an evolutionary accelerant may create a perfect storm for human IAV evolution in young children. Their naturally low hygiene likely results in transmission of higher doses with concomitant increases in genetic diversity. In combination with multiple contacts in a day care or school setting, children could be the primary source of highly adapted viruses. This is potentially one more reason for focusing efforts on increasing childhood IAV vaccination.
